Triglyceride glucose index in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study

Cardiovasc DiabetolPublished Prospective cohort study

Main finding · MACEResult — go to the resultHazard ratio 1.246 95% CI 1.064–1.459

Authors' conclusion

Our findings underscore a significant association between the TyG index and adverse cardiovascular outcomes, including cardiovascular and all-cause mortality, in ACS patients following PCI. The TyG index may thus function as an early predictor of cardiovascular risk or a potential therapeutic target in the management of cardiovascular disease.

Study context

Population
Patients with acute coronary syndrome (ACS) who underwent percutaneous coronary intervention (PCI), COSTIC registry
Participants
8,019 patients
Exposure
Triglyceride-glucose (TyG) index per IQR increment
Outcome
MACE: cardiovascular death, all-cause death, MI and stroke
Follow-up
1 year
Methodological detailsobservational, single-centre
  • Observational
  • Single-centre

Main finding

MACE · 1-year follow-up

Hazard ratio

1.246

95% CI 1.064–1.459

P = 0.006

TyG index per IQR increment
HR 1.246 (95% CI 1.064–1.459); P = 0.006

Per IQR increment, as printed

As reported in the abstract

Major adverse cardiovascular events (MACEs) documented
341

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
Cardiovascular death · 1-year follow-up1.409 (1.150–1.727)P = 0.001
All-cause death · 1-year follow-up1.368 (1.133–1.652)P = 0.001
Cardiovascular death — Cardiovascular deaths
197
All-cause death — All-cause deaths
242

Cardiovascular death · 1-year follow-up

No non-linear relationship (p-non-linear = 0.684)

All-cause death · 1-year follow-up

No non-linear relationship (p-non-linear = 0.827)

Stratified analyses

Significant interactions between TyG index and sex, smoking status and ACS diagnosis (p for interaction < 0.05)

Original publication

Triglyceride glucose index in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study. Cardiovasc Diabetol. Published 1 October 2025. doi:10.1186/s12933-025-02937-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.